Because the AKT pathway dictates multiple downstream processes, including inhibition of apoptosis, tumor-cell proliferation [13], and DNA repair [14], and is also known to be associated with radioresistance mechanisms, such as intrinsic radioresistance and hypoxia [15], inactivation of PTEN may affect the effectiveness of anticancer therapy. The gene discussed is PTEN; the disease is neoplasm.